Literature DB >> 17676428

Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice.

S Takagi1, N Hayakawa, H Kimoto, H Kato, T Araki.   

Abstract

We investigated the alteration of oligodendrocytes in comparison with that of astrocytes and microglia in the mouse striatum after MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropridine) treatment under the same conditions using Western blot analysis and Immunohistochemistry. In our Western blot analysis, four administrations of MPTP at 2-h intervals to mice produced the remarkable loss of TH (tyrosine hydroxylase) protein levels in the striatum after 3 and 7 days. In contrast, GFAP (glial fibrillary acidic protein) and Iba-1 protein in the striatum showed a significant increase of GFAP and Iba-1 protein levels 3 and 7 days after MPTP treatment. On the other hand, the levels of CNPase (2', 3'-cyclic nucleotide 3'-phosphodiesterase) protein were decreased significantly in the striatum 3 and 7 days after MPTP treatment. In our immunohistochemical study, a significant decrease in the area of expression of CNPase-positive profiles was observed in the striatum 3 and 7 days after MPTP treatment. These results demonstrate that oligodendrocytes in the striatum are damaged after MPTP treatment. Thus our present findings provide valuable information for the pathogenesis of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676428     DOI: 10.1007/s00702-007-0790-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

1.  Neuroprotection for Parkinson's disease: prospects and promises.

Authors:  C Warren Olanow; Anthony H V Schapira; Yves Agid
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

Review 2.  Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

Authors:  Bin Liu; Jau-Shyong Hong
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

Review 3.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

4.  Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals.

Authors:  E A Irving; K Yatsushiro; J McCulloch; D Dewar
Journal:  J Cereb Blood Flow Metab       Date:  1997-06       Impact factor: 6.200

5.  Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia.

Authors:  H Imai; H Masayasu; D Dewar; D I Graham; I M Macrae
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

Review 6.  Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination.

Authors:  Shin Hisahara; Hideyuki Okano; Masayuki Miura
Journal:  Neurosci Res       Date:  2003-08       Impact factor: 3.304

Review 7.  Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging.

Authors:  R C Melcangi; V Magnaghi; I Cavarretta; M A Riva; F Piva; L Martini
Journal:  Exp Gerontol       Date:  1998 Nov-Dec       Impact factor: 4.032

8.  Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.

Authors:  Hijiri Watanabe; Yasuko Muramatsu; Rumiko Kurosaki; Mari Michimata; Mitsunobu Matsubara; Yutaka Imai; Tsutomu Araki
Journal:  Eur Neuropsychopharmacol       Date:  2004-03       Impact factor: 4.600

9.  Interleukin-1 is an astroglial growth factor in the developing brain.

Authors:  D Giulian; D G Young; J Woodward; D C Brown; L B Lachman
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

Review 10.  Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors.

Authors:  N J Laping; B Teter; N R Nichols; I Rozovsky; C E Finch
Journal:  Brain Pathol       Date:  1994-07       Impact factor: 6.508

View more
  15 in total

1.  Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease.

Authors:  Hayato Kuroiwa; Hironori Yokoyama; Hiroki Kimoto; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

Review 2.  Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.

Authors:  Hironori Yokoyama; Hiroto Uchida; Hayato Kuroiwa; Jiro Kasahara; Tsutomu Araki
Journal:  Neurol Sci       Date:  2010-11-24       Impact factor: 3.307

3.  Glial damage after transient focal cerebral ischemia in rats.

Authors:  Shunsuke Matsuda; Masahiro Umeda; Hiroyuki Kato; Tsutomu Araki
Journal:  J Mol Neurosci       Date:  2008-12-03       Impact factor: 3.444

4.  Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice.

Authors:  Manami Abe; Hiroki Kimoto; Risa Eto; Taeko Sasaki; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

5.  Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats.

Authors:  S Matsuda; M Umeda; H Uchida; H Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2009-02-24       Impact factor: 3.575

6.  Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice.

Authors:  Takuya Oshikawa; Hayato Kuroiwa; Ryohei Yano; Hironori Yokoyama; Naoto Kadoguchi; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2009-04-16       Impact factor: 5.046

7.  Alterations of glial cells in the mouse hippocampus during postnatal development.

Authors:  Hiroki Kimoto; Risa Eto; Manami Abe; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

8.  Age-related changes of calcineurin and Akt1/protein kinase Balpha (Akt1/PKBalpha) immunoreactivity in the mouse hippocampal CA1 sector: an immunohistochemical study.

Authors:  Risa Eto; Manami Abe; Natsumi Hayakawa; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2008-09-04       Impact factor: 3.584

Review 9.  Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders.

Authors:  Jan Spaas; Lieve van Veggel; Melissa Schepers; Assia Tiane; Jack van Horssen; David M Wilson; Pablo R Moya; Elisabeth Piccart; Niels Hellings; Bert O Eijnde; Wim Derave; Rudy Schreiber; Tim Vanmierlo
Journal:  Cell Mol Life Sci       Date:  2021-03-10       Impact factor: 9.261

10.  Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice.

Authors:  Maik Ma Worlitzer; Eva C Bunk; Kathrin Hemmer; Jens C Schwamborn
Journal:  Stem Cell Res Ther       Date:  2012-08-14       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.